Laupacis, A. (2018). Evidence and Values: Requirements for Public Reimbursement of Drugs for Rare Diseases- A Case Study in Oncology- Reply. Journal of Population Therapeutics and Clinical Pharmacology, 16(2). https://mail.jptcp.com/index.php/jptcp/article/view/557